1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer - Clinckspoor, I; Verlinden, L; Overbergh, L (J Steroid Biochem Mol Biol, 2011)
et al.